Company / Profit Margin
Regenerative Medical Technology Group Inc. Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-153.2%
FY2025
5-year range
-2942.4% / -135.4%
FY2021-FY2025
Trend
-13.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 8 years, ranging from -10703.5% in FY2020 to -135.4% in FY2024.
Based on SEC 10-K filings.
-153.2% in FY2025 with a 5-year CAGR of +10550.3%.
Improved from -407.2% to -153.2% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +206.7pp
- 5-Year Change
- +10550.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 13.1% year-over-year.
- Peak profit margin was recorded in FY2024.
- Lowest profit margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -153.2% | -13.1% |
| FY2024 | -135.4% | +66.7% |
| FY2023 | -407.2% | -13.2% |
| FY2022 | -359.9% | +87.8% |
| FY2021 | -2942.4% | +72.5% |
| FY2020 | -10703.5% | -28.4% |
| FY2019 | -8335.2% | -103.0% |
| FY2018 | -4105.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026